NCT01923584View on ClinicalTrials.gov

A Phase 2A Trial of EPI-743 for Patients With Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

June 30, 2016

Conditions
Parkinson's Disease
Interventions
DRUG

EPI-743 400mg

DRUG

EPI-743 200mg

Trial Locations (1)

33612

University of South Florida, Tampa

Sponsors
All Listed Sponsors
collaborator

Edison Pharmaceuticals Inc

INDUSTRY

lead

University of South Florida

OTHER